LAVA Therapeutics N.V.

NASDAQ:LVTX

1.68 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -41.695-31.658-51.232-20.437-10.991
Depreciation & Amortization 1.2780.7810.6330.6060.294
Deferred Income Tax -0.279-0.249-0.178-0.0530
Stock Based Compensation 5.0394.1134.4290.6830.218
Change In Working Capital -2.82734.11312.2865.7080.705
Accounts Receivables 1.694-2.70.774-1.3090.037
Inventory 000-0.520
Accounts Payables 0.3341.4131.8340.347-0.216
Other Working Capital -3.16132.710.4527.190.883
Other Non Cash Items -0.488-3.0571.1430.691-0.192
Operating Cash Flow -38.9724.043-32.477-12.765-9.775
Investing Activities:
Investments In Property Plant And Equipment -0.73-0.587-0.866-0.659-0.865
Acquisitions Net 00000
Purchases Of Investments -90.082-70.877-51.3470-0.034
Sales Maturities Of Investments 73.17780.812.84600
Other Investing Activites -15.3139.276-42.6130-0.029
Investing Cash Flow -17.6359.346-49.367-0.659-0.899
Financing Activities:
Debt Repayment -1.041-0.343-0.385-0.315-0.109
Common Stock Issued 00106.78300
Common Stock Repurchased 00-5.858-6.1530
Dividends Paid 00000
Other Financing Activities 0.470.62670.83230.6651.443
Financing Cash Flow -0.5710.283171.37224.1971.334
Other Information:
Effect Of Forex Changes On Cash 1.076-4.208-4.441-1.214-0.491
Net Change In Cash -56.1029.46485.0869.559-9.83
Cash At End Of Period 44.231100.333103.01919.4298.326